Sandostatin
These highlights do not include all the information needed to use SANDOSTATIN INJECTION safely and effectively. See full prescribing information for SANDOSTATIN INJECTION. SANDOSTATIN (octreotide acetate) INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988
4e2c9856-1836-49f0-9472-4dbeeb408f39
HUMAN PRESCRIPTION DRUG LABEL
Nov 3, 2023
Novartis Pharmaceuticals Corporation
DUNS: 002147023
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
octreotide acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
octreotide acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
octreotide acetate
Product Details
FDA regulatory identification and product classification information